Technology Assessment and Valuation

The TCG team uses its deep scientific expertise combined with its hands-on commercial experience to quickly evaluate the product and market potential of diagnostic technologies.  We combine those insights with our financial analysis skills, deal-making experience and operations experience to accurately target the value of technology assets and licensing deals.

Some of our successes include:

• Completed a competitive technology assessment and asset valuation for a Fortune 50 company which was licensing and selling an patented biopharmaceutical manufacturing enabling technology.
• Completed a competitive technology valuation, and deal survey for a set of unique, first-to-market in vitro tools used to understand functional genomics and discover novel therapeutic targets for a biotechnology company licensing all of its assets to a Fortune 200 company.

"Commercialization is all part of brand management, how you build a brand. The companies who specialize in this may prove very helpful" says Dr. Robert Keefer. Read "Companies Supporting Other Companies" from The State of Life Sciences in North Carolina (Supplement) in The Scientist.

Getting FDA approval is the first crucial step in bringing a product to market. But negotiating reimbursement with the payers should have the same priority. This TCG White paper discusses the Do’s and Don’ts.